ReviewLife (Basel, Switzerland)2024

Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib.

Andrea Gazzin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.